Navigation Links
CEL-SCI Posts New Corporate Presentation to Website
Date:6/22/2009

VIENNA, Va., June 22 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that a new corporate presentation is available for review on the Company's website at http://www.cel-sci.com/investor_relations.html. The presentation includes information on CEL-SCI's plans to develop a vaccine to prevent and treat swine and other influenza viruses using its L.E.A.P.S.(TM) technology platform, provides details on its state-of-the-art facility in Maryland which it expects to utilize to launch aseptic filling for stem cell derived therapies and other biological products and includes a review of the science underlying Multikine(R), which the Company is preparing to commence a pivotal Phase III trial for the treatment of head and neck cancer.

CEL-SCI is developing products that empower immune defenses. Its lead product is Multikine(R) which is currently being readied for a global Phase III trial. The Company has operations in Vienna, Virginia, and Baltimore, Maryland.

www.cel-sci.com


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CEL-SCI Corporation Releases Letter to Shareholders
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
4. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
5. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
6. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
7. CEL-SCI Corporation Reports First Quarter Financial Results
8. CEL-SCI Corporation Announces 2007 Financial Results
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... May 4, 2017 Clarius Mobile Health, ... handheld ultrasound scanners this week at the American ... (ACOG) in San Diego, CA ... "Clarius is the perfect tool for clinicians to ... rate, and evaluate pregnancy-related complications like ectopic pregnancy ...
(Date:5/4/2017)... , May 4, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... or the "Company"), today announced that the Company,s first ... close on Thursday, May 11, 2017, and that the ... at 1:30 p.m. PT that afternoon. Management will provide ...
(Date:5/3/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: WST), ... drug administration, announced today that Fran DeGrazio ... and Diane Paskiet , Director, Scientific Affairs, ... on West,s expertise in the areas of safety ... providing commentary on updated industry guidance. ...
Breaking Medicine Technology:
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon ... informational blog post on insurance options. If a Bay Area patient has to search ... time and money. Visiting an in-network provider for a second opinion can ensure a ...
(Date:5/26/2017)... ... May 26, 2017 , ... Centennial-based ... of proceeds from its 14th Annual Clays for Kids fundraiser, to be held ... Bennett, Colorado. , As part of BluSky’s partnership with The Adoption Exchange, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the ... Jersey School District had left education officials with a number of critical issues to ... the flooring had to be accomplished with little or no disruption to class schedules. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is ... York City. He is known for his distinguished expertise and experience in the diagnosis ... holds sub-specialty training in treating renovascular disease and aortic aneurysm . He is ...
Breaking Medicine News(10 mins):